Thank you, Michael. On Page 4, we highlight the Company's key metrics for 2018. Net income was $29.9 million, an increase of $24.7 million from the prior year period. Pretax income including continuing and discontinued operations was $37.7 million, also up significantly from 2017. The increase in both metrics was primarily driven by improvement in income at our insurance business and the gain on sale of our senior living business. Partially offsetting those factors was $34.8 million of pretax unrealized losses on investments, $20.7 million was related to mark-to-market declines on our Invesque shares, and $6.9 million on our corporate loan portfolio. Operating EBITDA for the year was $54.9 million, down just under 10%. The year was positively impacted by growth in our insurance operations. But that positive performance was more than offset by lower distribution as a result of the prior sale of credit related investments, combined with the fact that capital was not yet fully redeployed into late 2018. On the bottom of the Page, we show a walk from operating EBITDA to total pretax income, highlighting the key differences between the two metrics. Book value per share increased to $10.79, up $0.82 from the prior year end, as the gain on the sale of our seniors housing business, improvement in insurance results, and share buybacks overcame any negative factors. Turning to Page 5, we highlight our capital allocated between specialty insurance and Tiptree capital along with the respective returns on that capital, in order to assist investors in understanding Tiptree value. When considering capital allocation decisions, we look at total capital which includes corporate debt held at the holding company and at our insurance subsidiary. We evaluate our return on capital using trailing 12 months operating EBITDA, which for the most recent period was $54.9 million. Our total return of approximately 8.4% is composed of a 14.4% return in specialty insurance and an 8% return in Tiptree capital. These returns were slightly lower than we would expect for two reasons. Just over $28 million of excess liquidity sits at the corporate level and has not yet been reinvested. In addition, the capital invested into shipping occurred in the second-half of the year. Corporate expenses remain stable as investments in infrastructure continue to provide opportunities to achieve scalable efficiencies. Now, let's turn to our specialty insurance results. On Page 7, we highlight our insurance underwriting performance and then on the following Page, returns from the insurance investment portfolio. We continue to see positive top line growth across our product line. In 2018, gross written premiums grew $100 million year-over-year up 13.0%. Retention of written premiums was stable at approximately 54%. As we continue to expand product offerings, we expect that retention rate may expand slightly overtime. Of our net written premiums, 24% was warranty and other specialty programs, up approximately three percentage points over the prior year driven primarily by other specialty program. Underwriting margin grew $14.4 million leading to growth in operating EBITDA of $11.2 million driven by strong performance in all our product lines. The 20.5% year-over-year growth in unearned premium reserves and deferred revenue on our balance sheet continues to demonstrate future revenue potential. Our combined ratio for the year was 92.5% a modest improvement from last year demonstrating our ability to continue to grow profitably in our insurance business. Turning to the insurance investment portfolio, our net investments grew by almost $66.8 million up 16.9% driven by our growth in net written premium. Our net investment income was $19.2 million up 17.8% driven by growth in the portfolio and rising interest income on our floating rate assets. Just over 20% of the $463 million portfolio is currently floating rate tied to LIBOR. Net portfolio income was $2.4 million up approximately $9.2 million versus the prior-year loss. The improved performance was driven by the same positive factors that drove net investment income plus lower unrealized losses and lower asset based interest expense. On Page 10, we present the results of Tiptree Capital which consist today of asset management operation, mortgage operation, our investment in ship and our Invesque share. Over time, we would expect that our investments could shift as we recognize returns in one asset class or business and reinvest in others. Our senior living results now a discontinued operation are presented here to facilitate period-over-period comparison. As of year-end 2018, our investment in Invesque represents $113.1 million of which $93.6 million is held in Tiptree Capital, the remainder is in our insurance portfolio. 50% of our Invesque shares are subject to transfer restrictions that extend through August 1, 2019. Given those restrictions under GAAP as of the end of the year, our valuation represents an approximate $5.5 million discount to the market value of Invesque shares most of which will accrete into our income statement over the remaining period. For 2018 the dividend income, unrealized loss on the shares, and the care gain are included in Real Assets. Real Assets also include operating EBITDA related to our shift for the part of the year they were included in our operation. Asset management and credit investment operating EBITDA was $2.9 million down $7.5 million from 2017 driven by the shift away from levered credit investments mentioned earlier. Mortgage operations were impacted by lower volumes and margin as mortgage interest rates have risen substantially over the past 12 months providing near-term headwinds for this business. Now we will turn the call back to Michael to conclude our prepared remarks.